Vvital Biomed

Vvital Biomed is developing a transcatheter mitral valve repair (VLR) solution that treats mitral regurgitation and prevents recurrence.

Founded December 2016; joined incubator: December 2018
Stage Technology development
Investor The Trendlines Group
CEO Nir Golan

Trendlines’ directors: Steve Rhodes, Barak Singer